Institut für Chemie, Technische Universität Berlin, Strasse des 17. Juni 124, 10623 Berlin, Germany.
Institut für Biochemie und Molekularbiologie, Universität Hamburg, 20146 Hamburg, Germany.
J Am Chem Soc. 2022 Jan 12;144(1):288-296. doi: 10.1021/jacs.1c09616. Epub 2021 Dec 30.
Paenilamicins are a group of complex polycationic peptide secondary metabolites with antibacterial and antifungal activities produced by the devastating honey bee brood pathogen causing the lethal brood disease American Foulbrood (AFB). Here, we report the convergent total synthesis and structural revision of paenilamicin B2. Specific stereoisomers of paenilamicin B2 were synthesized for unambiguous confirmation of the natural product structure and for evaluation of biological activities. These studies revealed the N-terminal fragment of paenilamicin as an important pharmacophore. Infection assays using bee larvae and the insect pathogen demonstrated that paenilamicins outcompete bacterial competitors in the ecological niche of . Finally, we show first data that classifies paenilamicins as potential ribosome inhibitors. Hence, our synthesis route is a further step for understanding the pathogenicity of and for thorough structure-activity-relationship as well as mode-of-action studies in the near future.
粘菌素是一组复杂的多阳离子肽类次生代谢物,具有抗菌和抗真菌活性,由毁灭性的蜜蜂幼虫病原体 产生,导致致命的幼虫病美国幼虫腐烂病(AFB)。在这里,我们报告了粘菌素 B2 的收敛性全合成和结构修订。为了明确确认天然产物结构和评估生物活性,合成了粘菌素 B2 的特定立体异构体。这些研究揭示了粘菌素 B2 的 N 端片段是一个重要的药效团。使用幼虫和昆虫病原体进行的感染实验表明,粘菌素在 的生态位中可以与细菌竞争物竞争。最后,我们首次提供的数据将粘菌素分类为潜在的核糖体抑制剂。因此,我们的合成路线是进一步了解 的致病性以及在不久的将来进行深入的结构-活性关系和作用模式研究的一步。